CTIC - Cell Therapeutics Inc. (NASDAQ)

[globalequitygroup]

GEG
when the FDA meets with CTIC in mid March, will there be some announcement or some transcript that we can review prior to the april 23rd decision date. I guess better way to ask is can the stock price be affected negatively as a result of the mid march meeting (delayed from feb meeting).

When the FDA Oncology Panel (Keep in mind this panel is made up of doctors and professors etc... not just FDA employees.) meets with CTIC on the 22nd they will recommend whether or not they think the FDA should approve Pixantrone on the 23rd of April. If they recommend against approval, then the stock will drop through the floor. If they recommend approval, then the stock will probably quadruple in price. The final decision will still be on the 23rd of April, but the March meeting is a leading indicator as to what the FDA will do.
There will an announcement shortly after the 3/22 meeting indicating as to what the FDA panel recommended.

So if you buy in ahead of the meeting in March, you are taking a huge gamble. If you buy in after the announcement, you will make money.

GEG.

[rhedayi]

Thank you so much, would you expect a run up until the March meeting ?

[globalequitygroup]

It will move up slowly. Not like a SOMX...

Many have lost confidence in CTIC. It is percieved as a junk trade by many.

There are 500,000,000 shares outstanding. This will tamper a run up even on approval...

Look at the outstanding shares for SOMX...Only 24 million.

[rhedayi]

To think I was in on SOMX at 2.80 and bailed out....I hate my decisions. Is it still a good idea to buy, everytime I buy, stocks seem to go down. The market makes a money off poorly informed investors like myself.

[globalequitygroup]

To think I was in on SOMX at 2.80 and bailed out....I hate my decisions. Is it still a good idea to buy, everytime I buy, stocks seem to go down. The market makes a money off poorly informed investors like myself.

A stock like SOMX even if it dips is going to be a intermediate term winner. Yes you should have held on. Get back in, and profit! I don't see any more major dips from here. Keep in mind all stocks, even the best, dip from time to time. Just look at Apple and Google recently. You just need to know how to read the signs and act according to your goals and objectives. If you are short term, exit on signals anr re-enter in a timely manner, If you ar long, hold on and you will likely be ok. Most here are short term, that is wht we give you the signals to watch and act on as you see fit. Take a look at 2nd quarter plays...Easily the most popular thread. You will see why. Should not lose like that if you follow the advice given. Not always right, but a pretty good track record for sure.

GEG.

[zetaseven]

ODAC panel reschedule meet with CTIC to 22/03/2010

Reference: Investors - Cell Therapeutics, Inc. - News Release

CEO James Bianco said in this PR:

"Our team is well-prepared to deliver an evidenced-based presentation to the ODAC panel, which we expect will provide a persuasive argument to the clinicians on the panel for the approval of pixantrone"

Dr. Owen O'Connor, Chief of Hematology Oncology at NYU Cancer Institute, and Dr. John Leonard, Chief of Lymphoma Myeloma at Weill Cornell Cancer Center will be presenting on behalf of CTI.

---

Gynecologic Oncology Group (GOG) Notifies CTI That Continuation of GOG-212 Pivotal Trial of OPAXIO Maintenance Therapy in Front Line Ovarian Cancer Remains High Priority

Reference: Investors - Cell Therapeutics, Inc. - News Release

[arif940]

Wow! What a large amount of bonus??Why they were given? For outstanding performance?! Few weeks before I read an article.where it was said CTIC selling additional share right before the FDA approval to operate the company cost....A few days later I read another article saying FDA raised concern on the number of enrollment in 3rd phase trial for the drug and it's side effect. Right after that a lot of similar article published and the stock of CTIC went down from $1.20 to $0.80 cent. Then due to the bad weather FDA panel review postponed 10th Feb meeting. During this time CTIC was trading between $0.50-$0.70. During last week FDA scheduled that meeting again to 22th of March. Since then the stock start moving high. Today CTIC management received bonus for their performance. The total bonus amount is unbelievable based on their performance! My concerns are:
1) If they had enough money to give bonus to their board members, then why they sold shares to maintain operation before FDA decision? Is the company management really concerned about their shareholders?
2) The articles published raising concern on CTIC drug approval why they are not writing any thing now? Was their article were to bring the stock price down so they can buy it at cheaper price?
3) Is the recent price in a early profit taking game or real?
Please think before you decide anything about this company. I lost personally a lot from this company in February due to this reason. I hope you guys don't loss and the choice is your to make. Good luck.

[jerrychengsf]

Hope every body Gain a lot from this stock

[drr08star]

Im just waiting for my account to open so I can put some buy some stocks from this company. If the evidence is convincing enough for the FDA to approve, this drug should be a homerun

[matx]

This is probably one of the most scary stocks to me right now.....dont know what to do! sell? add more at dips?